These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23805768)

  • 21. Dose individualisation in patients with renal insufficiency: does drug labelling support optimal management?
    Martin-Facklam M; Rengelshausen J; Tayrouz Y; Ketabi-Kiyanvash N; Lindenmaier H; Schneider V; Bergk V; Haefeli WE
    Eur J Clin Pharmacol; 2005 Jan; 60(11):807-11. PubMed ID: 15599503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nurse prescribing is falling behind.
    Ferguson D
    Nurs Times; 2000 Sep 28-Oct 4; 96(39):23. PubMed ID: 11968278
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of Model-Based Prediction of Pharmacokinetics in the Renal Impairment Population.
    Yee KL; Li M; Cabalu T; Sahasrabudhe V; Lin J; Zhao P; Jadhav P
    J Clin Pharmacol; 2018 Mar; 58(3):364-376. PubMed ID: 29077203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prescribing information in 26 countries: a comparative study.
    Reggi V; Balocco-Mattavelli R; Bonati M; Breton I; Figueras A; Jambert E; Kopp C; Montane E; Rägo L; Rocchi F;
    Eur J Clin Pharmacol; 2003 Aug; 59(4):263-70. PubMed ID: 12759794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacokinetic changes in renal failure].
    Launay-Vacher V; Storme T; Izzedine H; Deray G
    Presse Med; 2001 Mar; 30(12):597-604. PubMed ID: 11317921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contraindication labelling changes in the United States and Germany.
    Garbe E; Andersohn F
    Eur J Clin Pharmacol; 2007 Jan; 63(1):87-93. PubMed ID: 17124576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative assessment of four drug interaction compendia.
    Vitry AI
    Br J Clin Pharmacol; 2007 Jun; 63(6):709-14. PubMed ID: 17166171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimizing drug development and use in patients with kidney disease.
    Nolin TD; Arya V; Sitar DS; Pfister M
    J Clin Pharmacol; 2011 May; 51(5):628-30. PubMed ID: 21525394
    [No Abstract]   [Full Text] [Related]  

  • 29. [The enclosed notes with too much information].
    Weismann K; Larsen FG
    Ugeskr Laeger; 2001 Aug; 163(35):4762-4. PubMed ID: 11572057
    [No Abstract]   [Full Text] [Related]  

  • 30. What drug labels don't tell you.
    Consum Rep; 2011 Aug; 76(8):10. PubMed ID: 21770080
    [No Abstract]   [Full Text] [Related]  

  • 31. Stoning a dead bird: advertising limits on approved new drugs.
    Strobos J
    Food Drug Law J; 1995; 50(4):533-51. PubMed ID: 10343018
    [No Abstract]   [Full Text] [Related]  

  • 32. Applications of population pharmacokinetics in current drug labelling.
    Duan JZ
    J Clin Pharm Ther; 2007 Feb; 32(1):57-79. PubMed ID: 17286790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The one-size dose does not fit all. Physicians and patients should look beyond the guidelines recommended by drug manufacturers.
    Cohen JS
    Newsweek; 1999 Dec; 134(23):97. PubMed ID: 10724550
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug dosage in children with reduced renal function.
    Daschner M
    Pediatr Nephrol; 2005 Dec; 20(12):1675-86. PubMed ID: 16133064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Drug pharmacokinetics in renal failure: What's new?].
    Naud J; Dumayne C; Nolin TD; Leblond FA; Pichette V
    Nephrol Ther; 2015 Jun; 11(3):144-51. PubMed ID: 25861715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promoting safe medication use in pediatric patients.
    Honey BL; Condren M
    Res Social Adm Pharm; 2010 Dec; 6(4):269-71. PubMed ID: 21111384
    [No Abstract]   [Full Text] [Related]  

  • 37. Dosage adjustment in medical patients with renal impairment at Groote Schuur Hospital.
    Decloedt E; Leisegang R; Blockman M; Cohen K
    S Afr Med J; 2010 May; 100(5):304-6. PubMed ID: 20460024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biochemical bases of drug action. Introduction].
    Büchi J
    Pharm Acta Helv; 1968 Jun; 43(6):321-30. PubMed ID: 4880600
    [No Abstract]   [Full Text] [Related]  

  • 39. [More than 1 out of 100 will have myocardial infarction and stroke because of enalapril--effect of drug package inserts?].
    Sandström H
    Lakartidningen; 2006 Feb 22-28; 103(8):564, 567; discussion 567. PubMed ID: 16570783
    [No Abstract]   [Full Text] [Related]  

  • 40. Inactive ingredients in medicines.
    Wilson JV
    Lancet; 1988 Aug; 2(8607):399. PubMed ID: 2899806
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.